Do you have pancreatic cancer that is "locally advanced"? This means it can't be removed by surgery, but it hasn't spread elsewhere. Have you recently had chemotherapy, and your tumor has either shrunk or stopped growing? If so, you might be able to join a research study. The study looks at whether adding a high dose of radiation therapy can help people live longer or feel better compared to the usual treatment.

The purpose of Substudy 1 is to characterize the safety and tolerability of ABBV-453 in combination with other antimyeloma agents in subjects with Relapsed or Refractory (R/R) Multiple Myeloma (MM) and to determine the recommended Phase 2 doses (RP2D) of ABBV-453 in combination with daratumumab + dexamethasone (Dd) in subjects with R/R MM.

Do you have asthma? Would you like to learn about a new medicine that might help? We are looking for people aged 18-65 with asthma to join our study. You will be paid for your time. Compensation is provided.

The purpose of this study is to gather insight directly from people with eating disorders or who have cared for someone with an eating disorder about the ways the eating disorder has impacted areas of their life including education, work, social relationships, and participation in recreational or community activities.

This research study aims to investigate the use of circulating tumor DNA (ctDNA) monitoring to detect early signs of cancer recurrence in patients with triple-negative breast cancer (TNBC) after standard treatment. TNBC is aggressive and has a higher risk of recurrence, often detected only after symptoms appear. This study will monitor ctDNA levels through blood samples collected during and after adjuvant therapy. If ctDNA is not detected, participants will continue monitoring. If ctDNA is detected, the study offers an investigational treatment, datopotamab deruxtecan (Dato-DXd), to address this potential recurrence risk. Participation in this study will help determine if ctDNA monitoring can improve the early detection of recurrence and potentially lead to better treatment strategies and outcomes for patients with TNBC in the future.

Do you speak Spanish or identify as Hispanic or Latino and have cancer? You can help improve cancer care by sharing your experience. We need patients to complete a one-time survey about your health, background, and cancer treatment. Your input is important and can help others receive better care. Participation involves only a one-time survey, with no required medical tests. ¿Es usted un adulto hispano, latino o de habla hispana con cáncer? Puede ayudar a mejorar la atención del cáncer al compartir su experiencia. Le pedimos a los pacientes que completen una encuesta una sola vez sobre su salud, antecedentes y atención médica durante o después del tratamiento. Su voz es importante y puede ayudar a que otros reciban mejor atención. La participación consiste únicamente en una encuesta, sin pruebas médicas obligatorias.

Are you a caregiver to a child with Type 1 Diabetes? Do you live over an hour from your child's diabetes care team? The University of North Carolina is looking for volunteers for a study. We want to see how a telehealth program called REAL-Fam can help families manage diabetes and everyday tasks. You will get paid for participating.

Do you or your child have hidradenitis suppurativa? Would you be interested in hearing more about a clinical study on hidradenitis suppurativa? If so, you may be able to participate in a research study to find out how effective and safe the study medication Ruxolitinib is in patients with hidradenitis suppurativa.

Do you have protein in your urine and have had a kidney biopsy? You may be able to participate in a research study to test to see if a study drug can reduce the amount of protein in your urine.

The purpose of this study is to evaluate the distribution of a human leukocyte antigen genotype in adults who were recently diagnosed with type 1 diabetes